Cite
Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: Current status and future development
MLA
Cazzaniga, M., et al. Metronomic Oral Vinorelbine in Advanced Breast Cancer and Non-Small-Cell Lung Cancer: Current Status and Future Development. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1308932268&authtype=sso&custid=ns315887.
APA
Cazzaniga, M., Camerini, A., Addeo, R., Nolè, F., Munzone, E., Collovà, E., Del Conte, A., Mencoboni, M., Papaldo, P., Pasini, F., Saracchini, S., Bocci, G., Cazzaniga M, Camerini A, Addeo R, Nolè F, Munzone E, Collovà E, Del Conte A, … Bocci G. (2016). Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: Current status and future development.
Chicago
Cazzaniga, M, A Camerini, R Addeo, F Nolè, E Munzone, E Collovà, A Del Conte, et al. 2016. “Metronomic Oral Vinorelbine in Advanced Breast Cancer and Non-Small-Cell Lung Cancer: Current Status and Future Development.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1308932268&authtype=sso&custid=ns315887.